This day long programme will review the latest developments in medical surgery cornea and ocular surface.
We will be accepting single case presentation abstracts for inclusion in the programme for the Cornea Day.
| 08.30 |
J.L. Güell SPAIN, O. Gris SPAIN |
Limbal stem cells: Where are we today?
Panel: S. Daya UK, O. Gris SPAIN |
Cross-linking: Myths and reality
Panel: J. Colin FRANCE, O. Gris SPAIN |
12.05 |
H. Dua UK
In vivo confocal microscopy of the ocular surface:
clinicopathological correlation |
| 08.45 |
T. Seiler SWITZERLAND
Corneal collagen cross-link: from the basics to the
clinical use |
12.25 |
F. Kruse GERMANY
Reconstruction of the ocular surface by in vivo
expanded corneal an mucosal stem cells |
| 09.05 |
F. Malecaze FRANCE
Update on keratoconus pathophysiology. Cross link
and keratoconus |
12.45 |
S. Hannush
Keratoprothesis-permanent keratoprothesis:
The time is now |
| 09.25 |
A. Caporossi ITALY
Cross linking clinical results |
13.05 |
Clinical Cases
Discussion |
| 09.50 |
Clinical Cases
Discussion |
13.30 |
LUNCH |
10.15 |
BREAK |
|
High-risk keratoplasty: Is there something new?
Panel: M. Belin USA, H. Dua UK, J.L. Güell SPAIN
|
Femtosecond technology – Lamellar surgery:
A need for a corneal surgeon?
Panel: J.L. Güell SPAIN, S. Hannush USA,
R.D. Stulting USA |
| 10.35 |
F. Kruse GERMANY
The significance of corneal nerves for wound healing and the application of nerve growth factors
|
15.00 |
H. Dua UK
Deep anterior lamellar keratoplasty: The science
behind the surgery
|
| 10.55 |
M. Belin USA
The different uses of Cyclosporine for the prevention of rejection in high risk keratoplasty
|
15.20 |
V. Sarnicola ITALY
Deep posterior lamellar: Graft insertion by sutures:
Endothelial advantages
|
| 11.15 |
R.D. Stulting USA
Paediatric keratoplasty: long term follow-up |
15.40 |
S. Hannush USA
Endothelial keratoplasty – The new cornea triple
procedure: Technique and results
|
| 11.35 |
Clinical Cases
Discussion |
16.00 |
R. Nuijts NETHERLANDS
A randomized clinical trial of femtosecond laser
DSEK (FS-DSEK) versus penetrating keratoplasty (PK)
|
| |
|
16.20 |
Clinical Cases
Discussion
|
| 16.40 |
Closing Remarks
J. Colin FRANCE, J.L. Güell SPAIN, O. Gris SPAIN
|
| 16.45 |
End of Programme |
SPEAKERZONE LOGIN 
